Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 9/20 | 0.46 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | WNT1 | P04628 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.39 |
| ▸ | GAK | O14976 | 5/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15519766 | 0.86 | CFTR (0.48) | P2RX7PDK2HDAC1HDAC4HDAC6 | |
| SCHEMBL19611105 | 0.83 | TACR3 (0.48) | P2RX7PDK2ALDH1A1CYP3A4TSHR | |
| SCHEMBL16978806 | 0.76 | MAPK1 (0.58) | ALDH1A1CYP3A4TSHRHSD17B10TDP1 | |
| SCHEMBL30457735 | 0.74 | CFTR (0.47) | P2RX7PDK2ALDH1A1TSHRHSD17B10 | |
| SCHEMBL25275872 | 0.74 | CFTR (0.47) | P2RX7PDK2ALDH1A1TSHRHSD17B10 | |
| SCHEMBL28734981 | 0.74 | P2RX7 (0.53) | P2RX7PDK2ALDH1A1TDP1HDAC1 | |
| SCHEMBL19611108 | 0.72 | GAK (0.42) | GAK | |
| SCHEMBL15507256 | 0.70 | TTK (0.52) | P2RX7PDK2ALDH1A1CYP3A4TSHR | |
| SCHEMBL12479581 | 0.68 | QDPR (0.61) | ALDH1A1CYP3A4TSHRHSD17B10TDP1 | |
| SCHEMBL31065923 | 0.68 | P2RX7 (0.51) | P2RX7PDK2HDAC1HDAC4HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2892890-B1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS | CANCER RES TECH LTD (GB) | 2017-11-22 | — | — | EP | disclosed |